Back to search
FDAFDA · Food and drugs·Recall number D-1150-2022

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

Published June 22, 2022 · Recall initiated: June 10, 2022

Summary

FDA records drug Class II recall D-1150-2022, published June 22, 2022 and initiated June 10, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 3,216 bottles; Lot: Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.
Lot
Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16 recalled?

Yes. FDA published recall D-1150-2022 on June 22, 2022. Reported hazard: Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

What should I do if I have this product?

Voluntary: Firm initiated · Letter